The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell-free DNA (cfDNA) analysis and evaluation of BRAF amplifications and mutations in metastatic castration-resistant prostate cancer.
 
Peter Steinwald
No Relationships to Disclose
 
Elisa Ledet
No Relationships to Disclose
 
Bryce Raymon Christensen
No Relationships to Disclose
 
Marcus Marie Moses
No Relationships to Disclose
 
Lynne Chapman
No Relationships to Disclose
 
Ashkan Shahbandi
No Relationships to Disclose
 
Patrick Cotogno
No Relationships to Disclose
 
Joshua Schiff
No Relationships to Disclose
 
Jodi Lyn Layton
No Relationships to Disclose
 
Brian E. Lewis
No Relationships to Disclose
 
A. Oliver Sartor
Consulting or Advisory Role - AstraZeneca; Bayer; Bellicum Pharmaceuticals; Constellation Pharmaceuticals; Dendreon; Endocyte; Johnson & Johnson; Medivation; Oncogenex; Progenics; Sanofi; Tokai Pharmaceuticals; Tolmar
Research Funding - Bayer (Inst); Dendreon (Inst); Endocyte (Inst); Innocrin Pharma (Inst); InVitae (Inst); Johnson & Johnson (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bellicum Pharmaceuticals; Johnson & Johnson; Medivation; Oncogenex; Progenics; Sanofi; Tokai Pharmaceuticals